Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
Qualigen Therapeutics(US:QLGN) Globenewswire·2025-10-23 20:05New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or “Company”), a publicly-trading technology company majority owned by Faraday Future, today announced a strategic partnership with BitGo, the digital asset infrastructure company, to support its C10 treasury strategy, which accumulate and compound a market-cap-weighted basket of the world’s top 10 crypto assets (excluding stablecoins). Through this partnership, Qualigen will leverage BitGo’s holist ...